Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,592 | 5,187 | 3,395 | 1,883 | 3,368 |
| Operating Income | -4,592 | -5,187 | -3,395 | -1,883 | -3,368 |
| Interest Expense | -1 | 50 | 69 | 140 | 168 |
| Other Income | 0 | -186 | -228 | 20 | -212 |
| Pre-tax Income | -4,591 | -5,423 | -3,693 | -2,004 | -3,749 |
| Income Tax | -1,047 | -745 | N/A | N/A | N/A |
| Net Income Continuous | -3,544 | -4,678 | -3,693 | -2,004 | -3,749 |
| Net Income | $-3,544 | $-4,678 | $-3,693 | $-2,004 | $-3,749 |
| EPS Basic Total Ops | -135.88 | -652.38 | -192.31 | -34.97 | -55.94 |
| EPS Basic Continuous Ops | -136.31 | -410.73 | -53.43 | -29.00 | -54.23 |
| EPS Diluted Total Ops | -135.88 | -652.38 | -192.31 | -34.97 | -55.94 |
| EPS Diluted Continuous Ops | -136.31 | -410.73 | -53.43 | -29.00 | -54.23 |
| EBITDA(a) | $-4,590 | $-5,184 | $-3,390 | $-1,877 | $-3,334 |